Table 3. Clinical trials of ATG based regimen.

Auther	Country	N	Age	Treatment	Formulation	RA	HR
(Published year) ref			(Median)			(%)	(%)
Molldrem (2002)69	US	61	60	eATG	Atgam	61	34
Saunthararajah(2002)70	US	72	59	eATG and/or CsA	Atgam	46	29
Yazji (2003)71	US	31	59	eATG and CsA	Atgam	58	23
Steensma (2003)72	US	8	69	eATG	Atgam	25	0
Stadler (2004)73	Germany	35	63	eATG	Lymphoglobulin	60	40
				rATG	Thymoglobulin	80	27
Broliden (2006)74	Sweden	20	64	rATG and CsA	ATG Pharmacia	85	30
Lim (2007)75¶	UK, Germany, and Italy	96 (UK, 65: Germany, 13: Italy, 18)	56	eATG	Lymphoglobulin	84	42
Sloand (2008)§76	US	116 (eATG and CsA, 42: eATG, 74)	60	eATG and CsA	Atgam	67	48
				eATG			24

RA, refractory anemia; HR, hematological response; eATG, equine antithymocyte globulin; rATG, rabbit antithymocyte globulin; CsA, cyclosporine.

^¶Responses were defined by IWG ctiteria.

^§Responses were the same when the response classification of the IWG criteria was retrospectively applied.